Rosiglitazone in Treating Patients With Newly Diagnosed ACTH-Secreting Pituitary Tumor (Cushing Disease)

NCT00612066 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

2

Enrollment

OTHER

Sponsor class

Stopped Low accrual and funding term ended

Conditions

Cushing's Disease

Interventions

DRUG: rosiglitazone maleate

Sponsor

Jonsson Comprehensive Cancer Center

Collaborators

[object Object]